New Study Confirms Daxor’s BVA-100® Volume Metric Compared to CardioMEMS® Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients
March 23, 2023
Nemaura Medical Announces Receipt of Notice from Nasdaq
March 9, 2023
Related Post
-
-
Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients
March 23, 2023
-
ECGI Announces Binding LOI to Acquire 8bit Cannabis Brand as Target Distribution Widens to 20 Dispensaries
March 23, 2023
-
Alkaline88® Achieves Nationwide Distribution in Whole Foods Market
March 23, 2023